Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Almeida VH"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-7 z 7
    Tytuł:
    TF/PAR2 Signaling Axis Supports the Protumor Effect of Neutrophil Extracellular Traps (NETs) on Human Breast Cancer Cells.
    Autorzy:
    Martins-Cardoso K; Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
    Maçao A; Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
    Souza JL; Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
    Silva AG; Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
    König S; Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
    Martins-Gonçalves R; Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro 21040-360, Brazil.
    Hottz ED; Laboratory of Immunothrombosis, Department of Biochemistry, Federal University of Juiz de Fora (UFJF), Rio de Janeiro 23890-000, Brazil.
    Rondon AMR; Einthoven Laboratory for Experimental Vascular Medicine, Department of Thrombosis and Hemostasis, Leiden University Medical Center, 333 ZA Leiden, The Netherlands.
    Versteeg HH; Einthoven Laboratory for Experimental Vascular Medicine, Department of Thrombosis and Hemostasis, Leiden University Medical Center, 333 ZA Leiden, The Netherlands.
    Bozza PT; Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro 21040-360, Brazil.
    Almeida VH; Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
    Monteiro RQ; Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2023 Dec 19; Vol. 16 (1). Date of Electronic Publication: 2023 Dec 19.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Proteomic Analysis of HCC-1954 and MCF-7 Cell Lines Highlights Crosstalk between αv and β1 Integrins, E-Cadherin and HER-2.
    Autorzy:
    de Abreu Pereira D; Programa de Oncobiologia Celular e Molecular (POCM), Coordenação de Pesquisa, Instituto Nacional do Câncer, Rio de Janeiro 20231-050, Brazil.; Unidade de Espectrometria de Massas e Proteômica (UEMP), Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
    Sandim V; Unidade de Espectrometria de Massas e Proteômica (UEMP), Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.; Laboratório de Hemostase e Venenos (LABHEMOVEN), Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
    Fernandes TFB; Programa de Oncobiologia Celular e Molecular (POCM), Coordenação de Pesquisa, Instituto Nacional do Câncer, Rio de Janeiro 20231-050, Brazil.
    Almeida VH; Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
    Rocha MR; Programa de Oncobiologia Celular e Molecular (POCM), Coordenação de Pesquisa, Instituto Nacional do Câncer, Rio de Janeiro 20231-050, Brazil.
    do Amaral RJFC; Laboratório de Proliferação e Diferenciação Celular, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
    Rossi MID; Instituto de Ciências Biomédicas e Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-617, Brazil.
    Kalume DE; Laboratório Interdisciplinar de Pesquisas Médicas (LIPMed), Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-360, Brazil.
    Zingali RB; Unidade de Espectrometria de Massas e Proteômica (UEMP), Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.; Laboratório de Hemostase e Venenos (LABHEMOVEN), Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil.
    Pokaż więcej
    Źródło:
    International journal of molecular sciences [Int J Mol Sci] 2022 Sep 05; Vol. 23 (17). Date of Electronic Publication: 2022 Sep 05.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Breast Neoplasms*/metabolism
    Carcinoma, Hepatocellular*
    Liver Neoplasms*
    Cadherins/genetics ; Cell Line, Tumor ; Female ; Humans ; Integrin beta1/genetics ; Integrin beta1/metabolism ; MCF-7 Cells ; Proteomics ; Trastuzumab/pharmacology ; Trastuzumab/therapeutic use
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Neutrophil Extracellular Traps (NETs) Promote Pro-Metastatic Phenotype in Human Breast Cancer Cells through Epithelial-Mesenchymal Transition.
    Autorzy:
    Martins-Cardoso K; Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro 21941 590, Brazil.
    Almeida VH; Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro 21941 590, Brazil.
    Bagri KM; Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro 21941 590, Brazil.
    Rossi MID; Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro 21941 590, Brazil.; Clementino Fraga Filho University Hospital, Federal University of Rio de Janeiro, Rio de Janeiro 21941 913, Brazil.
    Mermelstein CS; Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro 21941 590, Brazil.
    König S; Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro 21941 590, Brazil.
    Monteiro RQ; Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, Rio de Janeiro 21941 590, Brazil.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2020 Jun 11; Vol. 12 (6). Date of Electronic Publication: 2020 Jun 11.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Pisum sativum Defensin 1 Eradicates Mouse Metastatic Lung Nodules from B16F10 Melanoma Cells.
    Autorzy:
    Amaral VSGD; Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brasil.; Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brasil.
    Santos SACS; Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brasil.
    de Andrade PC; Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brasil.; Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brasil.
    Nowatzki J; Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brasil.; Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brasil.
    Júnior NS; Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brasil.
    de Medeiros LN; Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brasil.
    Gitirana LB; Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brasil.
    Pascutti PG; Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brasil.
    Almeida VH; Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brasil.
    Monteiro RQ; Instituto de Bioquímica Médica Leopoldo de Meis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brasil.
    Kurtenbach E; Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ 21941-902, Brasil.
    Pokaż więcej
    Źródło:
    International journal of molecular sciences [Int J Mol Sci] 2020 Apr 11; Vol. 21 (8). Date of Electronic Publication: 2020 Apr 11.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Antineoplastic Agents, Phytogenic/*pharmacology
    Defensins/*pharmacology
    Lung Neoplasms/*pathology
    Lung Neoplasms/*secondary
    Pisum sativum/*chemistry
    Plant Proteins/*pharmacology
    Animals ; Antineoplastic Agents, Phytogenic/chemistry ; Apoptosis/drug effects ; Biopsy ; Cell Line ; Cell Membrane Permeability ; Cell Proliferation/drug effects ; Defensins/chemistry ; Disease Models, Animal ; Female ; Fluorescent Antibody Technique ; Glucosylceramides/metabolism ; Immunohistochemistry ; Lung Neoplasms/drug therapy ; Melanoma, Experimental ; Mice ; Models, Molecular ; Plant Proteins/chemistry ; Protein Conformation ; Structure-Activity Relationship
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Novel Aspects of Extracellular Vesicles as Mediators of Cancer-Associated Thrombosis.
    Autorzy:
    Almeida VH; Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, 21941-160 Rio de Janeiro, Brazil.
    Rondon AMR; Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, 21941-160 Rio de Janeiro, Brazil.
    Gomes T; Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, 21941-160 Rio de Janeiro, Brazil.
    Monteiro RQ; Institute of Medical Biochemistry Leopoldo de Meis, Federal University of Rio de Janeiro, 21941-160 Rio de Janeiro, Brazil. .
    Pokaż więcej
    Źródło:
    Cells [Cells] 2019 Jul 13; Vol. 8 (7). Date of Electronic Publication: 2019 Jul 13.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't; Review
    MeSH Terms:
    Neoplasms*/complications
    Neoplasms*/pathology
    Platelet Aggregation*
    Thrombosis*/complications
    Thrombosis*/metabolism
    Extracellular Traps/*metabolism
    Extracellular Vesicles/*metabolism
    Thromboplastin/*metabolism
    Animals ; Cell Line, Tumor ; Humans ; Neutrophils/cytology ; Neutrophils/metabolism ; Polyphosphates/metabolism
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Efficient blockade of Akt signaling is a determinant factor to overcome resistance to matuzumab.
    Autorzy:
    Meira DD; Coordination of Clinical Research, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.
    Almeida VH
    Mororó JS
    Caetano MS
    Nóbrega IP
    Batista D
    Sternberg C
    Ferreira CG
    Pokaż więcej
    Źródło:
    Molecular cancer [Mol Cancer] 2011 Dec 20; Vol. 10, pp. 151. Date of Electronic Publication: 2011 Dec 20.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Drug Resistance, Neoplasm*
    Antibodies, Monoclonal, Humanized/*pharmacology
    Antineoplastic Agents/*pharmacology
    Proto-Oncogene Proteins c-akt/*antagonists & inhibitors
    Cell Line, Tumor ; Cell Proliferation ; Cell Survival ; Down-Regulation ; ErbB Receptors/antagonists & inhibitors ; ErbB Receptors/metabolism ; Humans ; Proto-Oncogene Proteins c-akt/genetics ; Proto-Oncogene Proteins c-akt/metabolism ; Signal Transduction
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Combination of cetuximab with chemoradiation, trastuzumab or MAPK inhibitors: mechanisms of sensitisation of cervical cancer cells.
    Autorzy:
    Meira DD; Division of Clinical Research, Research Coordination, Instituto Nacional de Câncer (INCA), Rio de Janeiro, Cep: 20231-050, RJ, Brazil.
    de Almeida VH
    Mororó JS
    Nóbrega I
    Bardella L
    Silva RL
    Albano RM
    Ferreira CG
    Pokaż więcej
    Źródło:
    British journal of cancer [Br J Cancer] 2009 Sep 01; Vol. 101 (5), pp. 782-91. Date of Electronic Publication: 2009 Aug 04.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Antibodies, Monoclonal/*pharmacology
    Antineoplastic Agents/*pharmacology
    Enzyme Inhibitors/*pharmacology
    Uterine Cervical Neoplasms/*drug therapy
    Uterine Cervical Neoplasms/*radiotherapy
    Antibodies, Monoclonal, Humanized ; Apoptosis/drug effects ; Apoptosis/radiation effects ; Cell Cycle/drug effects ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cetuximab ; Cobalt Radioisotopes ; Combined Modality Therapy ; ErbB Receptors/antagonists & inhibitors ; ErbB Receptors/genetics ; ErbB Receptors/metabolism ; Female ; Humans ; Kinetics ; Mitogen-Activated Protein Kinases/antagonists & inhibitors ; Mitogen-Activated Protein Kinases/metabolism ; Phosphorylation ; RNA, Messenger/biosynthesis ; RNA, Messenger/drug effects ; Reverse Transcriptase Polymerase Chain Reaction ; Sensitivity and Specificity ; Trastuzumab ; Uterine Cervical Neoplasms/pathology ; Vascular Endothelial Growth Factors/antagonists & inhibitors ; Vascular Endothelial Growth Factors/biosynthesis ; Vascular Endothelial Growth Factors/metabolism
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-7 z 7

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies